Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 5/2019

01-05-2019 | Image of the Month

Monitoring response of advanced Merkel cell carcinoma to Avelumab with 18F-FDG PET/CT

Authors: Cecilia Vellani, Daniela D’Ambrosio, Luca Licata, Ilaria Vacchieri, Antonio Bernardo, Giuseppe Trifirò

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2019

Login to get access

Excerpt

Merkel cell carcinoma is a rare, aggressive skin cancer with few effective treatments and with poor prognosis in patients with advanced disease. …
Literature
1.
Kaufman H, Russel J, Hamid O, Bhatia S, Terheyden P, D’Angelo S, et al. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet Oncol. 2016;17:1374–85.CrossRefPubMedPubMedCentral
2.
3.
Esgghi N, Lundeen TF, MacKinnon L, Avery R, Kuo PH. 18F-FDG PET/CT for monitoring response of Merkel cell carcinoma to the novel programmed cell death ligand 1 inhibitor Avelumab. Clin Nucl Med. 2018;43:e142–4.
Metadata
Title
Monitoring response of advanced Merkel cell carcinoma to Avelumab with 18F-FDG PET/CT
Authors
Cecilia Vellani
Daniela D’Ambrosio
Luca Licata
Ilaria Vacchieri
Antonio Bernardo
Giuseppe Trifirò
Publication date
01-05-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2019
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-018-4230-x

Other articles of this Issue 5/2019

European Journal of Nuclear Medicine and Molecular Imaging 5/2019 Go to the issue

Original Article

Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study

Original Article

Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer

Original Article

Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study

Letter to the Editor

The mean striatal 18F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma

Image of the Month

Bronchial inflammatory granulation after endobronchial ultrasound-guided transbronchial needle aspiration and immunotherapy

Original Article

Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy?